Henry Schein, Inc. company logo

# 1st Gen Model Henry Schein, Inc. Medical & hospital equipment

75.56% successful of 90 deals
$70.16 Last close price
at 15-dec-2017


Model's trade recommendations 9.91% Return for period

-15.33% Annual return

$10.78B Market Cap

β 0.99  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 9.91%
52wk return -44.38%
52wk Range
Sortino ratio -0.24
Sharpe ratio -0.24
Norm. RMSE 0.56%
Downside risk 33.24%
Volatility 33.93%
  • BUY Analysts consensus recommendation

Henry Schein, a Fortune 500(R) company, is recognized for its excellent customer service and highly competitive prices. The Company's four business groups - Dental, Medical, International and Technology - serve more than 475,000 customers worldwide, including dental practices and laboratories, physician practices and veterinary clinics, as well as government and other institutions. The Company operates through a centralized and automated distribution network, which provides customers in more than 125 countries with a comprehensive selection of over 160,000 national and Henry Schein private-brand products. Henry Schein also offers a wide range of innovative value-added practice solutions, including such leading practice management software systems as DENTRIX(R) and Easy Dental(R) for dental practices, and AVImark(R) for veterinary clinics, which are installed in over 50,000 practices; and ArubA(R), Henry Schein's electronic catalog and ordering system.

Industry sector: Medical

Sector classification: Medical & hospital equipment

Deep Learning based analysis and prediction model for Henry Schein, Inc. (HSIC) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for HSIC model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 155M
P/E 19.27
Shares Outstanding 157M
% Held by Insiders 1.19%
% Held by Institutions 91.75%
EPS (last reported FY) $3.31
EPS (last reported Q) $0.87
EPS, estimated (last reported Q) $0.90
Total revenues $12 B
Net income $1 B